Cover Image

The impact of pneumococcal serotype replacement on the effectiveness of a national immunization program: a population-based active surveillance cohort study in New ZealandResearch in context

Summary: Background: In Aotearoa New Zealand (NZ) PCV7 was introduced in 2008, then PCV10 in 2011 and PCV13 in 2014. In 2017 PCV10 was re-introduced, replacing PCV13. In the present study, we investigate the resultant rapidly changing invasive pneumococcal disease (IPD) epidemiology. Methods: We com...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andrew Anglemyer (Author), Xiaoyun Ren (Author), Charlotte Gilkison (Author), Zoe Kumbaroff (Author), Julie Morgan (Author), Kara DuBray (Author), Audrey Tiong (Author), Arthur Reingold (Author), Tony Walls (Author)
Format:	Book
Published:	Elsevier, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is Pneumococcal Serotype Replacement Impending?
by: Chun-Yi Lu, et al.
Published: (2016)

Post-pandemic increase in invasive group A strep infections in New Zealand
by: Sherif Ammar, et al.
Published: (2024)

Demographic disparities in the incidence and case fatality of subarachnoid haemorrhage: an 18-year nationwide study from New ZealandResearch in context
by: Ilari Rautalin, et al.
Published: (2024)

Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey
by: Ayşe Büyükcam, et al.
Published: (2017)

The complexity of serotype replacement of pneumococci
by: Orsolya Dobay
Published: (2019)

Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New ZealandResearch in context
by: Jonathon Brooks, et al.
Published: (2023)

Invasive pneumococcal disease in relation to vaccine type serotypes
by: Paeton L. Wantuch, et al.
Published: (2019)

Connecting the health of country with the health of people: Application of 'caring for country' in improving the social and emotional well-being of Indigenous people in Australia and New ZealandResearch in context
by: Yaqoot Fatima, et al.
Published: (2023)

SEROTYPE CHARACTERISTIC OF PNEUMOCOCCI ISOLATED FROM PATIENTS WITH PNEUMOCOCCAL MENINGITIS
by: I. S. Koroleva, et al.
Published: (2012)

Pneumococcal Meningitis with Serotype 7 Who Develops 12. Nerve Paralysis
by: Fatma Kılınç, et al.
Published: (2023)

The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C
by: Yaru Shi, et al.
Published: (2023)

Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children
by: Josiah Ryman, et al.
Published: (2024)

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution
by: Patricia Izurieta, et al.
Published: (2018)

Pneumococcal serotype-specific IgG and opsonophagocytic activity in young Japanese patients with asplenia
by: Kenichi Takeshita, et al.
Published: (2021)

Pneumococcal serotype prevalence and antibiotic resistance in children in South and Southeast Asia, 2012-2024
by: Tzou-Yien Lin, et al.
Published: (2024)

Serotype spectrum of <i>S. pneumoniae</i> in children after the introduction of pneumococcal vaccine in Uzbekistan
by: E. A. Shamansurova, et al.
Published: (2024)

A pediatric case series of invasive pneumococcal disease caused by S.Pneumonia serotype-19A despite full dose vaccination
by: Burcu Ceylan Cura Yayla, et al.
Published: (2023)

Increase in incidence of invasive pneumococcal disease caused by serotype 3 in children eight years after the introduction of the pneumococcal conjugate vaccine in Hong Kong
by: Pak-Leung Ho, et al.
Published: (2019)

Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new pneumococcal conjugate vaccines
by: Michael Pichichero, et al.
Published: (2023)

Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017)

Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
by: Hoet Bernard, et al.
Published: (2010)

Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in Korea and Hong Kong
by: Salini Mohanty, et al.
Published: (2022)

Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines
by: Qian-qian Du, et al.
Published: (2021)

Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New ZealandResearch in context
by: Mercedes J. Burnside, et al.
Published: (2023)

Adult non-invasive pneumococcal pneumonia in Portugal is dominated by serotype 3 and non-PCV13 serotypes 3-years after near universal PCV13 use in children
by: Catarina Silva-Costa, et al.
Published: (2023)

"I haven't even taken them to the doctors, because I have that fear of what to expect": a qualitative description study exploring perceptions and experiences of early childhood healthcare among ethnically diverse caregivers in Aotearoa New ZealandResearch in context
by: Nadia A. Charania (Indian), et al.
Published: (2023)

The epidemiology of non-viral gastroenteritis in New Zealand children from 1997 to 2015: an observational study
by: Emma Jeffs, et al.
Published: (2019)

The epidemiology of listeriosis in pregnant women and children in New Zealand from 1997 to 2016: an observational study
by: Emma Jeffs, et al.
Published: (2020)

Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: A systematic review and meta-analysis
by: Kaile Chen, et al.
Published: (2018)

Pneumococcal serotypes missing prespecified efficacy threshold in immunogenicity trials: real-world evidence from national immunization programs
by: Johnna Perdrizet, et al.
Published: (2024)

Carriage Dynamics of Pneumococcal Serotypes in Naturally Colonized Infants in a Rural African Setting During the First Year of Life
by: Chrispin Chaguza, et al.
Published: (2021)

Streptococcus pneumoniae serotype 19A in hospitalized children with invasive pneumococcal disease after the introduction of conjugated vaccines in Lima, Peru
by: Theresa J. Ochoa, et al.
Published: (2024)

Assessment of the local clonal spread of Streptococcus pneumoniae serotype 12F caused invasive pneumococcal diseases among children and adults
by: Noriko Nakanishi, et al.
Published: (2019)

Radiographically confirmed community-acquired pneumonia in hospitalized adults due to pneumococcal vaccine serotypes in Sweden, 2016-2018-The ECAPS study
by: Karin Hansen, et al.
Published: (2023)

Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction
by: Fakhrul Islam, et al.
Published: (2012)

Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?
by: Maria L. Avila-Aguero, et al.
Published: (2017)

Pneumococcal disease in children in the Middle East and Northern Africa: A systematic literature review of clinical burden, serotype distribution, and vaccination programs
by: Dzhumber Ugrekhelidze, et al.
Published: (2024)

Response to: Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?
by: Javier Nieto Guevara, et al.
Published: (2018)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
by: Johnna Perdrizet, et al.
Published: (2021)

Distribution of 13-Valent pneumococcal conjugate vaccine serotype streptococcus pneumoniae in adults 50 Years and Older presenting with community-acquired pneumonia in Israel
by: Gili Regev-Yochay, et al.
Published: (2018)